Introduction
Angiotensin-converting enzyme (ACE) is an essential enzyme that has a role in the regulation of blood pressure, as well as fluid and electrolyte balance in the human body, as it modulates the renin-angiotensin-aldosterone system [1, 2] . ACE (a Zn 2+ -
Objective: To isolate, identify, and evaluate a new angiotensin-converting enzyme inhibitor from Peperomia pellucida (L.) Kunth herbs.
Methods: A dried sample of Peperomia pellucida herb was successively macerated with n-hexane and ethyl acetate. The ethyl acetate extract solution was evaporated to obtain the crude extract. Vacuum liquid column chromatography and thin layer chromatography were performed to obtain two pure compounds. Then, both compounds were elucidated and identified using the spectroscopic method. Angiotensin-converting enzyme inhibitory activity studies of both compounds were determined using angiotensin-converting enzyme kit WST-1 with spectrophotometer microplate reader 96-well at 450 nm wavelength. Results: Two bioactive compounds were successfully isolated from Peperomia pellucida herb, including a new compound of 2,3,5-trimethoxy-9-(12,14,15-trimethoxybenzyl)-1H-indene and pellucidin A. Both compounds demonstrated angiotensin-converting enzyme inhibitory activity, with IC 50 values of 72 µM (27.95 µg/mL) and 11 µM (4.4 µg/mL), respectively. Conclusions: In the present study, two active angiotensin-converting enzyme inhibitors were successfully isolated and purified from Peperomia pellucida which is used as an antihypertensive in traditional medicine, and support its use as an angiotensin-converting enzyme-inhibiting drug.
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binding metalloenzyme) increases the blood pressure when it is converted from angiotensin 栺 into the angiotensin 栻 , which acts a vasoconstrictor, thus contributing to hypertension [3] . Hypertension is a disease with reasonably high prevalence worldwide, causing blood pressure disorders and heart failure [4] . ACE is an ideal target for hypertension-controlling drugs [5, 6] , and several ACE inhibitors are widely available for the treatment of hypertension, including zofenopril, fosinopril, enalapril, ramipril, lisinopril, and captopril.
However, all ACE inhibitors produce unpleasant side effects including fatigue, dizziness, and headaches [2] .
Natural products have been the primary subjects of recent drug discovery. These studies have examined natural active compounds in an effort to discover new ACE inhibitors that are economical, safe to use, and of minimal side effects [5] [6] [7] . Since the development of an in vitro ACE inhibitory activity assay by Cushman and Cheung in 1971 [2] , drug discovery studies on ACE inhibitors from natural products have been more effective [8, 9] .
Peperomia pellucida (P. pellucida)(L.) Kunth herbs are one of the plant species that are traditionally used to lower blood pressure.
P. pellucida herb extract has ACE inhibitor activity with an IC 50 of 7.17 µg/mL [10] and the fraction and isolates (quercetin) have activity (IC 50 ) of 3.44 and 7.22 µg/mL [11] , respectively. This herb contains secondary metabolites such as alkaloid, saponin, terpenoid, and polyphenol [12] . Several polyphenolic compounds have been successfully isolated including dillapiole [13] , peperomins [14] , pellucidin A [15] , chromene [16] , and quercetin [11] . However, until now, only quercetin has been successfully demonstrated to have ACE inhibitory activity [11] . P. pellucida herb has enormous potential as a herbal medicine, but so far it has not been commercially used as herbal medicine and is still considered as a weed mainly by farmers in oil palm plantations. Also, it has a poor yield value (mainly in the form of simplicial and extract). On the other hands, it still needs further scientific data to confirm its use as herbal medicine or traditional medicine.
The present study aimed to isolate and identify new bioactive compounds from P. pellucida as potential ACE inhibitors. We report the successful isolation of two compounds with ACE inhibitory activity: pellucidin A (which it was first identified from P. pellucida herb extract by Bayma and his colleague [15] ) and a new compound of 2,3,5-trimethoxy-9-(12,14,15-trimethoxybenzyl)-1H-indene. To our knowledge, the in vitro ACE inhibition activity of both compounds has not previously reported.
Materials and methods

Reagents and apparatus
The reagents including n-hexane, ethyl acetate, chloroform, and methanol were purchased from PT. SmartLab Indonesia (West Java, Indonesia 
Extraction, isolation and structure elucidation
A dried sample of P. pellucida herbs (3 kg) was successively to obtain 6 sub-fractions (B1-B6), and then each fraction was tested for ACE inhibitor activity. The most active sub-fraction of B1 (1.28 g) was recrystallized using 50% chloroform (in methanol) to obtain crystal powder compounds. Based on the TLC profile, the crystal powder compound contains two spots and then was separated using preparative TLC with eluent n-hexane/ethyl acetate (2:1) to obtain both pure compounds including compound 1 (11.33 mg) and compound 2 (6.24 mg), respectively. Structure elucidation was performed using 
In vitro ACE inhibitory activity assay
The ACE inhibitory activity assay of 4,6,7-trimethoxy-1-(2,4,5-trimethoxybenzyl)-1H-indene (1) and Pellucidin A (2) was performed using an ACE Kit-WST1 (Doijindo Laboratories, Japan) according to the manufacturer's instructions and some literature [17] [18] [19] [20] . This assay was conducted on both isolated compounds using captopril as a positive control (to compare the amount of 3HB formed by ACE activity) and a blank containing no ACE for method validation. The assay used 3-hydroxybutyryglycylglycyl-glycine as the substrate, and the absorbance was measured at 450 nm using a VersaMax™ ELISA Microplate Reader. Captopril was used as a positive control. Based on the spectroscopic analyses, the structure of the compound isolated was determined as shown in Figure 1 . MHz) and 13 C-NMR (CDCl 3 , 500 MHz) ( Table 2 ). Based on the spectroscopic analyses, the structure of pellucidin A was determined as shown in Figure 2 according to the literature [15] . 
Identification of pellucidin A
ACE inhibitory activity
Discussion
This study successfully isolated, identified, and elucidated structurely two active compounds as an ACE inhibitor from P.
pellucida. Both compounds were separated and purified using column and preparative TLC. Moreover, the determination of structure of the compounds were conducted using the spectroscopic method. ACE inhibitor activity was also analyzed using an ACE analysis Kit-WST1. Based on the best of our knowledge, one of them is a novel compound (compound 1).
The molecular formula of novel compound (1) data with this reported in the literature [15] .
Since ACE was successfully isolated and identified from horse plasma (1954) (1955) (1956) (1957) , the discovery provides a significant impact in the development of the in vitro ACE inhibitor assay method [2] , the research and discovery of new ACE inhibitor drugs have become more productive. Medicinal plant biodiversity is a valuable resource for drug discovery, and medicinal plant-based products may be explored to combat hypertension. In the present study, we successfully isolated two compounds from the ACE-inhibitory fraction of P. pellucida herb extract, namely pellucidin A and a new compound. Pellucidin A is a dimeric ArC 2 that was initially reported by Bayma and his colleague [15] and 2,3,5-trimethoxy-9-(12,14,15-trimethoxybenzyl)-1H-indene is a novel compound, the structure of which was established in the present study.
In the present study, the positive control (captopril) had an IC 50 value of 1.08伊10 -7 µM, equivalent to 2.35伊10 -11 µg/mL. This result was similar to the results reported by Ibadallah and his colleagues [20] using the 3HB method (with an IC 50 value of 1.0伊10 -11 µg/mL).
Both compounds show inhibitory activity against ACE, with IC 50 values of 72 µM (equivalent to 27.95 µg/mL) and 11 µM (equivalent to 4.4 µg/mL), respectively. According to the inhibitory activity of these compounds (less than 50 µg/mL), both have the potential as pharmaceutical ACE inhibitors. However, two isolates show reduced activity compared to current ACE inhibitor drugs, although activity assays showed that 2,3,5-trimethoxy-9-(12,14,15-trimethoxybenzyl)-1H-indene had stronger ACE-inhibitory activity than quercetin compounds in the previous study [11] . Some studies have reported that other compounds have activities similar to those compounds in the present study, including compounds belonging to the phenolic group (gallic acid, vanillic acid, catechol pyrogallol), flavonoid group (quercetin, kaempferol, rutin, apigenin, epicatechin), and stilbene groups [21] , and also flavonoid-rich extract from Actinidia macrosperma [22] , and Onopordon acanthium [8] .
Until present, three bioactive compounds as ACE inhibitors have been found from P. pellucida herbs, including quercetin [11] , pellucidin A and a new compound of 2,3,5-trimethoxy-9-(12,14,15-trimethoxybenzyl)-1H-indene in this study. These compounds can be further developed into a pharmaceutical product as an antihypertensive herbal medicine with a green extraction approach as reported in a previous study [23] .
In conclusion, new ACE inhibitor compounds are successfully isolated and purified from P. pellucida in this study which is used as an antihypertensive in traditional medicine, and support its use as an angiotensin-converting enzyme-inhibiting drug. The compounds may be used as markers for the active ACE inhibitor extract/fraction of P. pellucida.
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